Kaneka Nutrients announces The International Coenzyme Q10 Association Ninth Scientific Meeting

Food and Healthcare Press Releases Tuesday November 14, 2017 09:07
PASADENA, Texas--14 Nov--PRNewswire/InfoQuest
June 21-24, 2018 at Columbia University, NYC

The International Coenzyme Q10 Association (ICQA; http://icqaproject.org/ ) is a non-profit organization that fosters basic and applied biomedical research on Coenzyme Q10 (CoQ10). Their mission is to advance knowledge on basic biochemistry and molecular genetics, as well as preventive and therapeutic effects of CoQ10.   Kaneka Nutrients ( www.kanekanutrients.com ) is a founding member and proud to partner with ICQA for the Ninth Scientific Meeting to be held in at Columbia University in New York City June 21 – 24, 2018.

"We have not held our Scientific Meeting in the United States in over 10 years.   As such, we are excited to bring this meeting back to the United States.   Previous Scientific Meetings have been held in Japan and Europe," said Dr. Placido Navas, Chairman of The International Coenzyme Q10 Association.

Every two to three years, nearly 350+ researchers and other professionals choose to attend the ICQA International Scientific Meeting to learn about the latest advances of Conventional CoQ10 and the Ubiquinol form of CoQ10, meet with colleagues from around the world and strike new collaborations.

The critical goals of the ICQA are to promote international collaborative research efforts to expand scientific knowledge and to optimize the use of CoQ10 as preventative and therapeutic interventions in human health. To achieve these important goals, ICQA organizes an international scientific meeting to present cutting-edge CoQ10 and Ubiquinol CoQ10 research in major clinical topics including: mitochondrial and degenerative diseases, aging, cardiovascular disorders, and nutritional supplementation needs and mechanisms that can benefit people suffering these conditions.

Dr. Navas added, "As in the 2015 Bologna Scientific Meeting, exciting sessions on the areas of CoQ10 and Ubiquinol CoQ10 research that have advanced significantly in the last few years will be presented including: mitochondrial diseases (primarily CoQ10 deficiency syndrome), cardiovascular diseases, diabetes, and aging. There is evidence of efficacy of CoQ10 supplementation in these conditions. Significantly, the European Medicines Agency has recently registered Ubiquinol as an orphan drug for CoQ10 deficiency syndrome."

Mark your calendars for this important Scientific Meeting to learn about the advances of Conventional CoQ10 and the Ubiquinol form of CoQ10.   Visit icqaproject.org for more information and to register.
Contact Information:
Ron Martin
Kaneka Nutrients
+1-281-291-3185

Latest Press Release

The Consumer Health of Merck Walks the Talk with its WE100 Movement

- Consumer Health accelerates its WE100(R) movement by launching new partnership programme with pharmacists in the UK on enabling 100 years of healthy living - Femibion(R) celebrates working mums with new "MumPlus" campaign - Expansion of Vitamin D brand...

Mindray launches BeneVision N1 for uninterrupted monitoring during intra and out-of-hospital patient transport

The revolutionary transport solution extends intelligent monitoring to out-of-hospital transport settings such as ambulances, helicopters, and civic flights. Mindray, a global medical equipment solution provider, announced the release of BeneVision N1...

Photo Release: Fujitsu works with the Thai Red Cross Society to contribute to society through the annual 20th FTH Voluntary Blood Donation Day

Ms. Krittinee Sivakul, Head of HR & Administration Group, Fujitsu (Thailand) Co., Ltd. (FTH) led a group comprising company management and staff at a special executives and 187 employees of the company recently donated blood to the Thai Red Cross...

Systech Europe(TM) Announces Rapid Expansion of Customer Base and Pharmaceutical Serialisation Partners Ready to Meet the FMD Regulation

Systech International , the global technology leader in serialisation, track and trace, and brand protection grew its European presence in 2017 by 50% with new accounts in France, Germany, Greece, Turkey, and Finland. The company also added new...

Fluke Biomedical VT650 and VT900 Gas Flow Analyzers offer the highest accuracy on the market

New analyzers deliver ease-of-use and reliability in measurements for all types of ventilators, flow meters, pressure gauges, anesthesia machines, and other devices Fluke Biomedical introduces the VT650 and VT900 Gas Flow Analyzers , which include...

Related Topics